Aytu BioPharma
373 Inverness Parkway, Suite 206
Englewood
Colorado
80112
United States
Website: http://aytubio.com/
141 articles about Aytu BioPharma
-
Aytu BioScience Announces Study Initiation And First Patient Dosing In Prostate Cancer Clinical Study With Hybridyne Imaging Technologies For Prostascint In Combination with Hybridyne's ProxiScan Transrectal Camera
6/6/2016
-
BIO2016: Aytu BioScience To Attend The 2016 Biotechnology Innovation Organization International Convention
5/31/2016
-
Aytu BioScience To Optimize Capitalization In Support Of Future Anticipated Uplisting Of Its Common Stock To A National Exchange
5/25/2016
-
Aytu BioScience To Present At 2016 Marcum MicroCap Conference
5/24/2016
-
Aytu BioScience Initiates Commercial Expansion To Support July 2016 Launch Of Natesto
5/18/2016
-
Aytu BioScience Provides Third Fiscal Quarter 2016 Business Update
5/11/2016
-
Aytu BioScience Demonstrates Expanded Clinical Utility Of MiOXSYS For Assessing Oxidative Stress As A Marker For Male Infertility With New Study
5/10/2016
-
Aytu BioScience Announces Closing Of Public Offering
5/6/2016
-
Aytu BioScience To Provide Its Third Fiscal Quarter Business Update
5/5/2016
-
Aytu BioScience Announces Pricing Of $7.5 Million Public Offering Of Common Stock And Warrants
5/3/2016
-
Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto
4/25/2016
-
Aytu BioScience Strengthens Board With Appointment Of First Independent Director
4/13/2016
-
Aytu BioScience Demonstrates Clinical Utility of MiOXSYS For Measuring Oxidative Stress Levels In Semen As A Marker For Male Infertility At American Society Of Andrology 41st Annual Meeting In New Orleans, LA
4/5/2016
-
Aytu BioScience Awarded Health Canada Approval For Its Mioxsys System For Male Infertility
3/31/2016
-
Aytu BioScience Announces U.S. Co-Promotion Agreement For Primsol
3/29/2016
-
Aytu BioScience Announces Study Collaboration With Hybridyne Imaging Technologies, Inc. For Minimally Invasive Prostate Cancer Detection
3/1/2016
-
Aytu BioScience Provides Second Fiscal Quarter Business Update
2/17/2016
-
Aytu BioScience To Provide Its Second Fiscal Quarter Business Update
2/11/2016
-
Aytu BioScience Announces First Commercial Sales For Company's MiOXSYS System For Male Infertility
2/9/2016
-
Aytu BioScience To Present At 2016 Disruptive Growth & Healthcare Conference
2/3/2016